Research activity

Claudio Brancolini is the first or corresponding author in 73% of the 96 PubMed indexed scientific publications. The H-index is 45 (Google Scholar) or 38 (Scopus). Total citations of his manuscripts are >18.340 (Google Scholar) or>11.450 (Scopus).

  • Publications

96 Scientific publications on peer-reviewed international journals in PubMed

J. Biol. Chem. (9); Mol. Biol. Cell. (5); Cell Death Diff, (5), J Cell Biol., (4); J. Cell Sci.,(3); Dev. Biol. (2);); Mol Cell. Biol. (5); Drug Resist Updates (2); Autophagy (3); Adv.C. Phat. (2), Cancer Res. (2); Cell Death Disease (2), Mol. Cancer Ther. (2), Cancers (2), Nucleic Acid Res (2), Epigenomics (2), EMBO J., (2);  Mol Oncol. (2), Genes Dev, (1); Exp. Cell. Res. (1); Genomics, (1); J. Neurosc. (1); J. Neurochem. (1); Gene (1); Neurobiol. Dis. (1); Oncogene (1); Leukemia (1); Curr Mol Pharm (1); AJTR (1), Apoptosis (1), Cytokine Growth Factor Review (1) Cell. Signal (1),Meth Mol Biol (1). JCMM (1) FASEBJ (1) Proc. Natl. Acad. Sci. USA, (1) Cancer Biol & Therapy (1) PlosOne (1) Cell Mol. Life Sci. (1) J Med Chem (1) Oncotarget (1), Cell Cycle (1) CurrMedChem (1) Cells (1), Cancer Gene Ther (1), Life (1), Int J Mol Sci. (1)  PLOSGenetics (1), J Cachexia Sarcopenia Muscle (1), Pharma. Therap. (1), Front Immunol.(1), Genome biology (1), Mol. Biomedicine (1), Biochim Biophys Acta Rev Cancer (1). Cell Death Discovery (1), Pharma. Therap. (1), RSC Adv. (1), Front Mol Biosci (1),

70 Scientific publications on peer-reviewed journals as first or corresponding author in PubMed

J. Biol., Chem. (6), Mol. Biol. Cell. (5),  J Cell Biol. (3), Mol. Cell. Biol (3); J. Cell Sci. (3), Cell Death Diff. (2),Epigenomics (2),  Drug Resist Update (2), Cell Death & Disease (2), Ad.C.Phat. (2) Cancer Res. (2) Mol. Cancer Ther (2), Epigenomics (2), Cancers (2), Nucleic Acid Res (2), Curr Mol Pharm (1).  Autophagy (1) AJTR (1) Dev. Biol. (1) Proc. Natl. Acad. Sci. USA, (1); EMBO J. (1), JCMM (1), FASEBJ (1), Meth Mol Biol ( 1), Apoptosis (1), CGFR (1) Cell. Signal (1) Cancer Biol & Therapy (1) PlosOne (1) Cell Mol. Life Sci. (1) J Med Chem (1) ) Oncotarget (1), Cell Cycle (1) PLoS Genetics (1), Cytokine Growth Factor Review (1), Cells (1), Cancer Gene Ther (1), Life (1), Int J Mol Sci. (1), Cells (1), Genome biology (1), Mol. Biomedicine (1), Biochim Biophys Acta Rev Cancer (1), Pharma. Therap. (1). Cell Death Discovery (1), Front Mol Biosci (1). 

  • Research Grants on competitive bases

Research activities in his Lab have been supported by different agencies including: 

·       Italian Ministry of University and Research PRIN, different years since 2000, currently (2019-22)

·       Italian Ministry of University and Research FIRB 2003 and 2010.

·       Italian Association for Cancer Research (AIRC), various years 2001-2017 Currently (2022-2026)

·       Telethon, 2001-2003

·       National Research Council, 1999-2001

·       Italian Ministry for Health, (2002 and 2005)

·       Regione Friuli-Venezia Giulia, (2005, 2009, 2017)

·       Consorzio Interuniversitario per le Biotecnologie (2004)

·       EU-cofounded Interreg projects ITA-SLO 2016-2018 and currently ITA-AUS, (as coordinator of the project) 2019-2022

Tipo Informazione: